Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,384Revenue $M7,477Net Margin (%)-3.2Altman Z-Score0.9
Enterprise Value $M27,893EPS $-0.2Operating Margin %-4.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-8.7Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow47.5y-y EBITDA Growth Rate %-84.2ROA % (ttm)-1.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,345ROIC % (ttm)-0.6Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMario Gabelli 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 16.64-7%Reduce -2.96%821,746
BSXDodge & Cox 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 16.64-7%Reduce -4.68%450,830
BSXVanguard Health Care Fund 2015-09-30 Add0.16%$15.78 - $18.02
($17.1)
$ 16.64-3%Add 7.52%64,108,690
BSXMario Gabelli 2015-09-30 Reduce-0.01%$15.78 - $18.02
($17.1)
$ 16.64-3%Reduce -12.09%846,846
BSXDodge & Cox 2015-09-30 Reduce$15.78 - $18.02
($17.1)
$ 16.64-3%Reduce -19.60%472,960
BSXMario Gabelli 2015-06-30 Reduce-0.03%$17.18 - $18.51
($17.87)
$ 16.64-7%Reduce -26.90%963,296
BSXDodge & Cox 2015-06-30 Reduce$17.18 - $18.51
($17.87)
$ 16.64-7%Reduce -19.36%588,260
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 16.645%Reduce -20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 16.645%Reduce -38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 16.6430%Reduce -97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 16.6430%Add 16.36%59,624,800
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 16.6432%Sold Out0
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 16.6432%Add 19.88%51,242,050
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 16.6428%Reduce -23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 16.6428%Add 16.19%42,743,200
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 16.6441%Reduce -36.64%8,533,099
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 16.6441%Add 17.65%2,000,000
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 16.6441%Reduce -22.34%45,938,468
BSXVanguard Health Care Fund 2013-12-31 Reduce-0.06%$11.18 - $12.38
($11.82)
$ 16.6441%Reduce -3.80%36,787,000
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 16.6441%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Prange KarenSVP&Pres, Uro & Pelvic Health 2016-02-08Sell6,216$16.053.68view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-01-08Sell7,160$17.67-5.83view
Phalen Michael P.EVP & President, MedSurg 2016-01-08Sell18,221$17.67-5.83view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2016-01-07Sell19,059$17.73-6.15view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2016-01-05Sell16,114$18-7.56view
Mirviss Jeffrey B.SVP&Pres, Periph Intervent 2016-01-05Sell9,953$18-7.56view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2015-12-01Sell24,000$18.43-9.71view
MARIO ERNESTDirector 2015-11-16Sell125,000$17.63-5.62view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-11-09Sell4,469$18.68-10.92view
Fitzgerald Joseph MichaelEVP & President, CRM 2015-11-09Sell26,220$18.58-10.44view

Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
    Third Point's Third Quarter Letter Nov 02 2015 
    Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
    Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 

    More From Other Websites
    How Did Boston Scientific’s Stock Move after Its 4Q15 Earnings Release? Feb 10 2016
    Weighing in with Boston Scientific’s 4Q15 Revenues Feb 10 2016
    Here’s Why Boston Scientific (BSX) Stock is Rising Today Feb 09 2016
    Boston Scientific Announces Medicare Will Cover WATCHMAN™ Left Atrial Appendage Closure Device Feb 08 2016
    Boston Scientific inks $31M deal with FedEx, to split complex in Quincy Feb 08 2016
    Boston Scientific Scores Earnings Beat amid CRM Headwinds Feb 08 2016
    Despite Currency Headwinds, Boston Scientific Maintained Strong Growth Momentum In Q4 Feb 08 2016
    Credit Suisse Picks 7 Health Care Stocks to Own for the Next 6 Months Feb 06 2016
    Boston Scientific Corp. Earnings Analysis: 2015 By the Numbers Feb 05 2016
    Earnings Recap For February 4 Feb 04 2016
    Edited Transcript of BSX earnings conference call or presentation 4-Feb-16 1:00pm GMT Feb 04 2016
    GoPro (GPRO), Ralph Lauren (RL) and 3 Other Companies Join the Growing List of Stocks Battered by... Feb 04 2016
    Heart device maker Boston Scientific's sales miss estimates Feb 04 2016
    Boston Scientific Tops Q4 Earnings; CRM Remains a Drag Feb 04 2016
    Abiomed, Boston Scientific Move Opposite Ways On Quarterly Reports Feb 04 2016
    Boston Scientific (BSX) Stock Declining After Earnings Results Feb 04 2016
    Boston Scientific Corp Earnings Call scheduled for 8:00 am ET today Feb 04 2016
    Boston Scientific (BSX) Tops Q4 Earnings, Lags Revenue Estimates Feb 04 2016
    [$$] Boston Scientific Narrows Loss as Sales Rise Feb 04 2016
    Boston Scientific matches profit expectations, but sales fall shy Feb 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK